Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Corbus Pharmaceuticals Hldgs Inc (CRBP)

Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 177,297
  • Shares Outstanding, K 10,687
  • Annual Sales, $ 0 K
  • Annual Income, $ -44,600 K
  • EBIT $ -40 M
  • EBITDA $ -39 M
  • 60-Month Beta 2.53
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.49

Options Overview Details

View History
  • Implied Volatility 75.19% ( -0.09%)
  • Historical Volatility 284.35%
  • IV Percentile 7%
  • IV Rank 2.51%
  • IV High 222.54% on 09/19/24
  • IV Low 71.39% on 10/16/24
  • Put/Call Vol Ratio 0.44
  • Today's Volume 288
  • Volume Avg (30-Day) 1,127
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 9,393
  • Open Int (30-Day) 21,666

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.99
  • Number of Estimates 6
  • High Estimate -0.78
  • Low Estimate -1.14
  • Prior Year -2.27
  • Growth Rate Est. (year over year) +56.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.49 +0.73%
on 10/24/24
23.33 -28.80%
on 09/26/24
-1.73 (-9.43%)
since 09/24/24
3-Month
16.49 +0.73%
on 10/24/24
61.90 -73.17%
on 07/31/24
-37.85 (-69.50%)
since 07/24/24
52-Week
3.03 +447.57%
on 11/13/23
61.90 -73.17%
on 07/31/24
+10.79 (+185.40%)
since 10/24/23

Most Recent Stories

More News
Up 174% in 2024, Is It Too Late to Buy This Breakout Biotech Stock?

After more than doubling in the past year, is this clinical-stage biotech stock still a buy?

CRBP : 16.77 (+1.08%)
$SPX : 5,810.52 (+0.23%)
NVO : 114.28 (-1.26%)
MRK : 105.78 (-0.56%)
LLY : 893.27 (-1.10%)
ABBV : 189.95 (+1.10%)
PFE : 28.61 (-0.87%)
XBI : 97.10 (+0.44%)
BMY : 52.72 (-0.64%)
Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)

CRBP : 16.77 (+1.08%)
Corbus Pharmaceuticals: Q2 Earnings Snapshot

Corbus Pharmaceuticals: Q2 Earnings Snapshot

CRBP : 16.77 (+1.08%)
Up Over 700% YTD, Here's How Much Higher Analysts Think This Biotech Stock Can Rise

As the biotech industry rebounds from recent challenges, a favorable regulatory environment and groundbreaking scientific advancements are creating investment opportunities, particularly in companies with...

CRBP : 16.77 (+1.08%)
Stocks Climb on Lower Bond Yields and Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.11%. US stocks this morning...

$SPX : 5,810.52 (+0.23%)
SPY : 579.50 (+0.26%)
$DOWI : 42,392.36 (-0.29%)
DIA : 423.84 (-0.31%)
$IUXX : 20,233.55 (+0.83%)
QQQ : 492.68 (+0.88%)
ZNZ24 : 111-070 (+0.17%)
INCY : 65.17 (-0.14%)
AAPL : 230.65 (-0.05%)
WYNN : 98.07 (+0.40%)
LVS : 52.52 (+2.90%)
MGM : 40.23 (+1.49%)
Corbus Pharmaceuticals: Q1 Earnings Snapshot

Corbus Pharmaceuticals: Q1 Earnings Snapshot

CRBP : 16.77 (+1.08%)
Corbus Pharmaceuticals: Q4 Earnings Snapshot

Corbus Pharmaceuticals: Q4 Earnings Snapshot

CRBP : 16.77 (+1.08%)
Mira Pharmaceuticals Stock Is Soaring In November... Here's Why

Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m

MIRA : 1.0961 (+2.44%)
CARA : 0.2599 (-2.29%)
CRBP : 16.77 (+1.08%)
HRMY : 33.99 (-0.18%)
JAZZ : 108.02 (-2.80%)
Corbus Pharmaceuticals: Q3 Earnings Snapshot

Corbus Pharmaceuticals: Q3 Earnings Snapshot

CRBP : 16.77 (+1.08%)
Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on its Anti-aVb8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that an...

CRBP : 16.77 (+1.08%)

Business Summary

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic...

See More

Key Turning Points

3rd Resistance Point 18.55
2nd Resistance Point 18.12
1st Resistance Point 17.36
Last Price 16.77
1st Support Level 16.17
2nd Support Level 15.74
3rd Support Level 14.98

See More

52-Week High 61.90
Fibonacci 61.8% 39.41
Fibonacci 50% 32.47
Fibonacci 38.2% 25.52
Last Price 16.77
52-Week Low 3.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar